XML 30 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule II. Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2019
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]  
Schedule II. Condensed Financial Information of Registrant

Schedule II. Condensed Financial Information of Registrant

AMERISAFE, INC.

CONDENSED BALANCE SHEETS

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

 

(in thousands)

 

Assets:

 

 

 

 

 

 

 

 

Investments:

 

 

 

 

 

 

 

 

Fixed maturity securities—available-for-sale, at fair value

   (amortized cost $7,210 and $0, in 2019 and 2018, respectively)

 

$

7,216

 

 

$

 

Equity securities, at fair value (cost $10,007 in 2019 and 2018)

 

 

11,779

 

 

 

9,803

 

Short-term investments

 

 

17,967

 

 

 

 

Investment in subsidiaries

 

 

379,001

 

 

 

388,797

 

Total investments

 

 

415,963

 

 

 

398,600

 

Cash and cash equivalents

 

 

10,551

 

 

 

5,509

 

Deferred income taxes

 

 

 

 

 

509

 

Notes receivable from subsidiaries

 

 

2,781

 

 

 

3,270

 

Property and equipment, net

 

 

1,720

 

 

 

1,536

 

Federal income tax recoverable

 

 

2,798

 

 

 

2,995

 

Other assets

 

 

804

 

 

 

800

 

Total assets

 

$

434,617

 

 

$

413,219

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

Accounts payable and other liabilities

 

 

4,230

 

 

 

3,457

 

Deferred income taxes

 

 

172

 

 

 

 

Total liabilities

 

 

4,402

 

 

 

3,457

 

Shareholders' equity (net of Treasury stock of $22,370 at December 31, 2019 and 2018)

 

 

430,215

 

 

 

409,762

 

Total liabilities and shareholders' equity

 

$

434,617

 

 

$

413,219

 

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF INCOME

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

$

915

 

 

$

1,089

 

 

$

679

 

Net unrealized gains (losses) on equity securities

 

 

1,977

 

 

 

(948

)

 

 

 

Fee and other income

 

 

5,352

 

 

 

7,389

 

 

 

6,890

 

Total revenues

 

 

8,244

 

 

 

7,530

 

 

 

7,569

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Other operating costs

 

 

8,244

 

 

 

7,530

 

 

 

7,569

 

Total expenses

 

 

8,244

 

 

 

7,530

 

 

 

7,569

 

Income (loss) before income taxes and equity in earnings of subsidiaries

 

 

 

 

 

 

 

 

 

Income tax expense (benefit)

 

 

376

 

 

 

(36

)

 

 

125

 

Gain (loss) before equity in earnings of subsidiaries

 

 

(376

)

 

 

36

 

 

 

(125

)

Equity in net income of subsidiaries

 

 

93,066

 

 

 

71,596

 

 

 

46,356

 

Net income

 

$

92,690

 

 

$

71,632

 

 

$

46,231

 

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF CASH FLOWS

 

  

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Operating activities

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

2,333

 

 

$

2,448

 

 

$

15,138

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of investments

 

 

(27,140

)

 

 

(47,825

)

 

 

(37,361

)

Proceeds from sales of investments

 

 

1,987

 

 

 

54,600

 

 

 

33,000

 

Purchases of property and equipment

 

 

(995

)

 

 

(1,041

)

 

 

(277

)

Dividends from subsidiary

 

 

115,900

 

 

 

65,400

 

 

 

78,900

 

Net cash provided by investing activities

 

 

89,752

 

 

 

71,134

 

 

 

74,262

 

Financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from stock option exercises

 

 

20

 

 

 

67

 

 

 

 

Finance lease purchases

 

 

(47

)

 

 

 

 

 

 

Dividends to shareholders

 

 

(87,016

)

 

 

(84,491

)

 

 

(82,645

)

Net cash used in financing activities

 

 

(87,043

)

 

 

(84,424

)

 

 

(82,645

)

Change in cash and cash equivalents

 

 

5,042

 

 

 

(10,842

)

 

 

6,755

 

Cash and cash equivalents at beginning of year

 

 

5,509

 

 

 

16,351

 

 

 

9,596

 

Cash and cash equivalents at end of year

 

$

10,551

 

 

$

5,509

 

 

$

16,351